147 related articles for article (PubMed ID: 21480204)
1. Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.
Borinstein SC; Barkauskas DA; Krailo M; Scher D; Scher L; Schlottmann S; Kallakury B; Dickman PS; Pawel BR; West DC; Womer RB; Toretsky JA
Cancer; 2011 Nov; 117(21):4966-76. PubMed ID: 21480204
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumors.
Toretsky JA; Steinberg SM; Thakar M; Counts D; Pironis B; Parente C; Eskenazi A; Helman L; Wexler LH
Cancer; 2001 Dec; 92(11):2941-7. PubMed ID: 11753970
[TBL] [Abstract][Full Text] [Related]
3. Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study.
Borinstein SC; Barkauskas DA; Bernstein M; Goorin A; Gorlick R; Krailo M; Schwartz CL; Wexler LH; Toretsky JA
Pediatr Blood Cancer; 2014 Apr; 61(4):749-52. PubMed ID: 24178953
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic relevance of the IGF pathway in Ewing's sarcoma patients.
van de Luijtgaarden AC; Versleijen-Jonkers YM; Roeffen MH; Schreuder HW; Flucke UE; van der Graaf WT
Target Oncol; 2013 Dec; 8(4):253-60. PubMed ID: 23292309
[TBL] [Abstract][Full Text] [Related]
5. [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors].
Mohnike K; Kluba U; Blum WF; Aumann V; Vorwerk P; Mittler U
Klin Padiatr; 1995; 207(4):225-9. PubMed ID: 7564158
[TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase.
Grill CJ; Sivaprasad U; Cohick WS
J Mol Endocrinol; 2002 Aug; 29(1):153-62. PubMed ID: 12200236
[TBL] [Abstract][Full Text] [Related]
7. Glucagon Decreases IGF-1 Bioactivity in Humans, Independently of Insulin, by Modulating Its Binding Proteins.
Sarem Z; Bumke-Vogt C; Mahmoud AM; Assefa B; Weickert MO; Adamidou A; Bähr V; Frystyk J; Möhlig M; Spranger J; Lieske S; Birkenfeld AL; Pfeiffer AFH; Arafat AM
J Clin Endocrinol Metab; 2017 Sep; 102(9):3480-3490. PubMed ID: 28911141
[TBL] [Abstract][Full Text] [Related]
8. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
Lassarre C; Duron F; Binoux M
J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer.
Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
Tumour Biol; 2014 Sep; 35(9):9303-9. PubMed ID: 24943688
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population.
Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Rigaud AS; Labourée F; Epelbaum J; le Bouc Y; Hanon O
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):854-9. PubMed ID: 25384548
[TBL] [Abstract][Full Text] [Related]
12. The IGF-I response to very low rhGH doses is preserved in human ageing.
Arvat E; Ceda G; Ramunni J; Lanfranco F; Aimaretti G; Gianotti L; Broglio F; Ghigo E
Clin Endocrinol (Oxf); 1998 Dec; 49(6):757-63. PubMed ID: 10209563
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
[TBL] [Abstract][Full Text] [Related]
14. The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children.
Turan S; Bereket A; Furman A; Omar A; Berber M; Ozen A; Akbenlioglu C; Haklar G
Eur J Clin Nutr; 2007 Jun; 61(6):752-8. PubMed ID: 17164829
[TBL] [Abstract][Full Text] [Related]
15. The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ).
Shen X; Xi G; Wai C; Clemmons DR
J Biol Chem; 2015 May; 290(18):11578-90. PubMed ID: 25787077
[TBL] [Abstract][Full Text] [Related]
16. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum insulin-like growth factor-I in burn patients: relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support.
Abribat T; Nedelec B; Jobin N; Garrel DR
Crit Care Med; 2000 Jul; 28(7):2366-72. PubMed ID: 10921566
[TBL] [Abstract][Full Text] [Related]
20. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
Thierry van Dessel HJ; Chandrasekher Y; Yap OW; Lee PD; Hintz RL; Faessen GH; Braat DD; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
